JUN 13, 2018 5:42 AM PDT

Psychedelics May Serve as Potential Treatment for Depression

WRITTEN BY: Nouran Amin

Research at the University of California is examining the effect of hallucinogenic drugs on the brain and how this research can potentially provide some answers in treating depression and other mental disorders. The latest findings have shown the ability of these psychedelic drugs to change the neurons and glial cells present in the brains of rat and flies; primarily increasing the connectivity between neuronal cells.

Although depression has long been believed to be asocated with chemical imbalances in the brain, recent research has provided evidence of how structural changes in parts of the brain can also be associated with depression. For example, in a recent fMRI study, the hippocampus was found to be around 9 to 13 percent smaller among individuals afflicted with depression.

Senior author David E. Olson discussed that “one of the hallmarks” of depression is the presence of shriveled up neurites in the prefrontal cortex of the brain. The prefrontal cortex is the region of the brain concerned with emotion and mood regulation. “People have long assumed that psychedelics are capable of altering neuronal structure, but this is the first study that clearly and unambiguously supports that hypothesis,” he said. “What is really exciting is that psychedelics seem to mirror the effects produced by ketamine.”

Despite multiple limitations, Ketamine was studied to have antidepressant properties. Olson and co-researchers were particularly interested in how psychedelics could hold the similar effects of ketamine on neurons grown in a petri dish. But after treatment with a dose of DMT (a psychedelic compound), rats had an increase in the number of dendritic spines, which was similar when these rat model were treated with ketamine.

"These are some of the most powerful compounds known to affect brain function, it's very obvious to me that we should understand how they work," said Olson. With these research findings, it was crucial to bring the risks of psychedelics into light. For one, the drugs could induce forms of psychotic disorders particularly in individuals who are genetically predisposed.

The researchers tested psychedelics from the amphetamine, tryptamine, and ergoline drug classes. Talaverabeads/Pixabay, Image via MedicalDaily.com

A professor of clinical psychiatry, by the name of Richard A. Friedman, at the Weill Cornell Medical College, believes that psychedelics may be behaviorally toxic, as well as an addictive similar to cocaine or alcohol. “Psychedelics might turn out to have real promise, but that needs to be proven through large, rigorous, placebo-controlled trials. We’re not there yet,” he cautioned.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 15, 2020
Drug Discovery & Development
Turmeric Better than Placebo for Osteoarthritis Pain
SEP 15, 2020
Turmeric Better than Placebo for Osteoarthritis Pain
Researchers from the University of Tasmania in Australia have found that an extract from turmeric is more effective than ...
SEP 27, 2020
Cell & Molecular Biology
How Spiders May Open a Path to IBS Treatment
SEP 27, 2020
How Spiders May Open a Path to IBS Treatment
Irritable bowel syndrome (IBS) is term that describes a gut disorder that causes abdominal pain, cramping, diarrhea or c ...
OCT 20, 2020
Drug Discovery & Development
New Treatment Reverses Late Stage Type 2 Diabetes
OCT 20, 2020
New Treatment Reverses Late Stage Type 2 Diabetes
Researchers from the Netherlands have developed a minimally invasive therapeutic procedure that allows people to discont ...
OCT 22, 2020
Neuroscience
Placebos Impact Brain Patterns for Emotional Processing
OCT 22, 2020
Placebos Impact Brain Patterns for Emotional Processing
Researchers from Michigan State University have found that placebos reduce markers of emotional distress- even when the ...
OCT 29, 2020
Cardiology
Treating Cardiovascular Calcification at the Source
OCT 29, 2020
Treating Cardiovascular Calcification at the Source
The term cardiovascular disease covers a broad array of health problems. Everyone tends to think of heart attacks or hyp ...
OCT 10, 2020
Drug Discovery & Development
Fishnet of Nanoparticles Traps Drug Molecules
OCT 10, 2020
Fishnet of Nanoparticles Traps Drug Molecules
‘Fishnet’ Nanoparticles Traps Drug Molecules A team at Northwestern University have casted a net of nanopart ...
Loading Comments...